Status:
COMPLETED
Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis t...
Detailed Description
Randomized, Double Blind, Placebo-Controlled, Single-Dose, Parallel-Group Study to Evaluate the Onset of Action of a Single Dose of Intranasal GW685698X Aqueous Nasal Spray 100 mcg in Adolescent and A...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Informed consent
- Outpatient
- Females must use appropriate contraception
- Diagnosis of seasonal allergic rhinitis
- Able to comply with study procedures
- Literate
- Exclusion criteria:
- Significant concomitant medical condition
- Use of corticosteroids, allergy medications, or tobacco
- Clinically significant abnormal ECG
- Laboratory abnormality
- Positive pregnancy test
- Allergy to any component of investigational product
Exclusion
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT00118729
Start Date
April 1 2005
End Date
August 1 2005
Last Update
September 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Woodstock, Georgia, United States, 30188